Bicycle Therapeutics plc Cash Equivalents, at Carrying Value
Bicycle Therapeutics plc (BCYC) had Cash Equivalents, at Carrying Value of $364.20 million as of 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-03-17
- 2025-12-31: Cash Equivalents, at Carrying Value $364.20M.
- 2024-12-31: Cash Equivalents, at Carrying Value $664.90M.
- 2024-03-31: Cash Equivalents, at Carrying Value $22.40M.
- 2023-12-31: Cash Equivalents, at Carrying Value $72.30M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2025-12-31 | $364.20M 10-K · filed 2026-03-17 |
| 2024-12-31 | $664.90M 10-K · filed 2026-03-17 |
| 2024-03-31 | $22.40M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $72.30M 10-K · filed 2025-02-25 |
| 2023-09-30 | $63.40M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $3.80M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $256.10M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $276.10M 10-K · filed 2024-02-20 |
| 2022-09-30 | $276.10M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $200.00M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $100.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $100.00M 10-K · filed 2023-02-28 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |